BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11113514)

  • 1. The role of opioid receptors in morphine withdrawal in the infant rat.
    McPhie AA; Barr GA
    Brain Res Dev Brain Res; 2000 Nov; 124(1-2):73-80. PubMed ID: 11113514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence.
    Feng YZ; Zhang T; Tokuyama S; Zhu H; Rockhold RW; Ho IK
    Neurochem Res; 1996 Jan; 21(1):63-71. PubMed ID: 8833225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat.
    Funada M; Schutz CG; Shippenberg TS
    Eur J Pharmacol; 1996 Apr; 300(1-2):17-24. PubMed ID: 8741160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists.
    Maldonado R; Negus S; Koob GF
    Neuropharmacology; 1992 Dec; 31(12):1231-41. PubMed ID: 1335131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system.
    Le Guen S; Gestreau C; Besson JM
    Eur J Neurosci; 2003 Jun; 17(11):2425-37. PubMed ID: 12814374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective mu and delta, but not kappa, opiate receptor antagonists inhibit the habituation of novelty-induced hypoalgesia in the rat.
    Spreekmeester E; Rochford J
    Psychopharmacology (Berl); 2000 Jan; 148(1):99-105. PubMed ID: 10663423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists.
    Zhu H; Barr GA
    Psychopharmacology (Berl); 2000 Jun; 150(3):325-36. PubMed ID: 10923761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The unconditioned fear produced by morphine withdrawal is regulated by mu- and kappa-opioid receptors in the midbrain tectum.
    De Ross J; Avila MA; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
    Behav Brain Res; 2009 Dec; 204(1):140-6. PubMed ID: 19520121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioidergic modulation of ethanol self-administration in the ventral pallidum.
    Kemppainen H; Raivio N; Suo-Yrjo V; Kiianmaa K
    Alcohol Clin Exp Res; 2012 Feb; 36(2):286-93. PubMed ID: 21895714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injections of an opioid antagonist into the locus coeruleus and periaqueductal gray but not the amygdala precipitates morphine withdrawal in the 7-day-old rat.
    Jones KL; Barr GA
    Synapse; 2001 Feb; 39(2):139-51. PubMed ID: 11180501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats.
    Kelsey JE; Verhaak AM; Schierberl KC
    Behav Brain Res; 2015 Apr; 283():16-21. PubMed ID: 25591478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone, naltrindole, and CTOP block cocaine-induced sensitization to seizures and death.
    Braida D; Paladini E; Gori E; Sala M
    Peptides; 1997; 18(8):1189-95. PubMed ID: 9396060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord.
    Catheline G; Le Guen S; Besson JM
    Brain Res; 1999 Apr; 824(1):105-11. PubMed ID: 10095048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies of the role of opioid receptors in the nigra in the morphine withdrawal syndrome.
    Baumeister AA; Richard AL; Richmond-Landeche L; Hurry MJ; Waguespack AM
    Neuropharmacology; 1992 Sep; 31(9):835-41. PubMed ID: 1359441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramuscular administration of morphine reduces mustard-oil-induced craniofacial-muscle pain behavior in lightly anesthetized rats.
    Han SR; Lee MK; Lim KH; Yang GY; Jeon HJ; Ju JS; Yoon YW; Kim SK; Ahn DK
    Eur J Pain; 2008 Apr; 12(3):361-70. PubMed ID: 17768078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid receptor subtype control of galanin-induced feeding.
    Barton C; York DA; Bray GA
    Peptides; 1996; 17(2):237-40. PubMed ID: 8801527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats.
    Hyytiä P; Kiianmaa K
    Alcohol Clin Exp Res; 2001 Jan; 25(1):25-33. PubMed ID: 11198711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative involvement of spinal opioid receptors in physical dependence on intrathecal butorphanol and morphine.
    Wongchanapai W; Tsang BK; He Z; Ho IK
    Pharmacol Biochem Behav; 1998 Aug; 60(4):899-907. PubMed ID: 9700974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats.
    Steinmiller CL; Young AM
    Psychopharmacology (Berl); 2008 Jan; 195(4):497-507. PubMed ID: 17882404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.